Family Medicine Doctors in Shady Grove, PA Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Dr. David R Hess Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1964 Buchanan Tr E, Shady Grove, PA 17256 Phone: 717-597-7131 Fax: 717-597-0898 |
News Archive
Tips to protect your sleep during the COVID-19 pandemic
The COVID-19 pandemic has changed the lives of many throughout the UK, most people are unable to go to work, some have seen their hours cut, some have had their job prospects changed, and for the general population their normal routine is upset, which means their sleeping pattern may be compromised too.c
Abnormal androgen signaling in ovaries cause female infertility
Male sex hormones, such as testosterone, have well defined roles in male reproduction and prostate cancer. What may surprise many is that they also play an important role in female fertility. A new study finds that the presence and activity of male sex hormones in the ovaries helps regulate female fertility, likely by controlling follicle growth and development and preventing deterioration of follicles that contain growing eggs.
Dr. Peter G. Goldschmidt announces recipients of Awards for Excellence in Human Research Protection
Awards for Excellence in Human Research Protection were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.
Shingles vaccine can help protect elderly patients with end-stage renal disease
Elderly patients with end-stage renal disease (ESRD) who received the shingles vaccine were half as likely to develop shingles compared to those who were not vaccinated. The new study from Kaiser Permanente, published in Clinical Infectious Diseases, also found the best protection against shingles was achieved when patients received the vaccination shortly after beginning dialysis.
Webinar to assist pharmaceutical companies on how to measure effectiveness of Medication Guides
More than 80 Risk Evaluation and Mitigation Strategy (REMS) plans have been approved by the Food & Drug Administration since their inception in March 2008. Now, pharmaceutical companies must formally assess and report on how well these plans have actually been working in reducing drug risks, a mandated step in the REMS process.
› Verified 8 days ago